Search results
Ted Danson Has Lived With Psoriasis for 50 Years—Here Are the Dermatologist-Approved Ways He Combats...
Eating Well via Yahoo News· 3 days agoActor Ted Danson and dermatologist Jennifer Soung shared the importance of seeking care for...
Does the Anti-Inflammatory Diet for Psoriasis Help Manage Symptoms?
Verywell Health via Yahoo News· 6 days agoInflammation is one of the underlying causes of psoriasis, and research shows that an...
How Does Psoriasis Affect Pregnancy?
Verywell Health via Yahoo News· 3 days agoExperiencing psoriasis during pregnancy is unlikely to pose a risk for your fetus, but it can affect each person differently. Here’s what you need to...
Ted Danson on Managing His Psoriasis With Humor
WebMD· 5 days agoActor Ted Danson, known for his roles on sitcoms like Cheers and The Good Place, was diagnosed with plaque psoriasis when he was 25 years old. Danson, now ...
These Pictures Will Help You Identify the Most Common Skin Rashes
Prevention via Yahoo News· 1 day agoFrom eczema to allergic reactions to bug bites, here’s what common skin rashes look like in photos,...
Oruka Therapeutics Expands Leadership Team, Naming Joana Goncalves, MBChB, as Chief Medical Officer
Morningstar· 4 days agoOruka Therapeutics, Inc. (“Oruka”), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases, including plaque< ...
Two Biosimilars Approved in Europe for Autoimmune Disorders
Medscape· 2 days agoThe drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's...
What Can Cause a Rash Around the Eyes?
Verywell Health via Yahoo News· 6 days agoMany conditions can cause a rash around the eyes, from infections to dermatological conditions like dermatitis or psoriasis. Here’s what you need to...
VENTYX BIOSCIENCES, INC. (NASDAQ: VTYX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Ventyx...
Morningstar· 6 days agoDo you, or did you, own shares of Ventyx Biosciences, Inc. (NASDAQ: VTYX)? Did you purchase your shares pursuant and/or traceable to the Company’s October 21, 2021 IPO, or between October 21 ...
FDA Approval of Alvotech/Teva Ustekinumab Biosimilar | JD Supra
JD Supra· 5 days agoOn April 16, Alvotech and Teva announced the FDA approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Johnson and Johnson’s STELERA® (ustekinumab). The product was approved as a subcutaneous ...